Malignant otitis externa in an infant with selective IgA deficiency: a case report

A C Paul1, A Justus, A Balraj

  • 1Department of Child Health, Christian Medical College and Hospital, Vellore 632004, Tamil Nadu, India.

Insights

Malignant otitis externa (MOE) is rare in infants. This case highlights MOE in a neonate with selective IgA deficiency, successfully treated with ciprofloxacin but resulting in long-term complications.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Otolaryngology

Background:

  • Malignant otitis externa (MOE) is a severe necrotizing infection of the external auditory canal, typically seen in the elderly with diabetes.
  • Infantile MOE is exceptionally rare, with limited documented cases and treatment protocols.

Observation:

  • A neonate presented with clinical signs consistent with MOE.
  • Subsequent investigations revealed the infant had selective IgA deficiency, an uncommon immunodeficiency.

Findings:

  • The neonate was treated with oral ciprofloxacin, achieving clinical improvement.
  • Despite successful treatment, the infant developed significant sequelae including external auditory canal stenosis, pinna deformity, persistent facial nerve palsy, temporal bone erosion, and hearing loss.

Implications:

  • This case represents the first reported instance of MOE in a patient with selective IgA deficiency.
  • It is also the first report detailing the use of ciprofloxacin for MOE in an infant.
  • The findings underscore the potential for severe outcomes and the need for vigilant monitoring in infants with MOE, particularly those with underlying immunodeficiencies.